ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 78 filers reported holding ATHIRA PHARMA INC in Q2 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,430,875 | -31.5% | 1,698,453 | 0.0% | 0.00% | – |
| Q2 2023 | $5,010,436 | +8.8% | 1,698,453 | -7.8% | 0.00% | – |
| Q1 2023 | $4,606,613 | -20.9% | 1,842,645 | +0.3% | 0.00% | – |
| Q4 2022 | $5,826,248 | +7.1% | 1,837,933 | +0.3% | 0.00% | – |
| Q3 2022 | $5,441,000 | +10.8% | 1,832,030 | +13.7% | 0.00% | – |
| Q2 2022 | $4,912,000 | -75.9% | 1,610,580 | +6.6% | 0.00% | – |
| Q1 2022 | $20,400,000 | +2.0% | 1,511,078 | -1.6% | 0.00% | – |
| Q4 2021 | $20,005,000 | +29.9% | 1,535,241 | -6.5% | 0.00% | – |
| Q3 2021 | $15,397,000 | +9.9% | 1,641,483 | +20.0% | 0.00% | – |
| Q2 2021 | $14,004,000 | -2.4% | 1,367,599 | +75.5% | 0.00% | – |
| Q1 2021 | $14,342,000 | -35.2% | 779,468 | +20.6% | 0.00% | -100.0% |
| Q4 2020 | $22,131,000 | +1098.2% | 646,165 | +546.2% | 0.00% | – |
| Q3 2020 | $1,847,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 1,704,362 | $3,442,811 | 3.16% |
| Simplify Asset Management Inc. | 1,492,792 | $3,015,440 | 0.34% |
| Perceptive Advisors | 4,797,278 | $9,690,501 | 0.32% |
| Nan Fung Group Holdings Ltd | 180,000 | $363,600 | 0.29% |
| Potomac Capital Management, Inc. | 74,585 | $150,662 | 0.19% |
| Acuitas Investments, LLC | 149,600 | $302,192 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 352,715 | $712,484 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 297,052 | $600 | 0.05% |
| Integrity Financial Corp /WA | 32,786 | $66,228 | 0.05% |
| Laird Norton Wetherby Trust Company, LLC | 178,709 | $360,992 | 0.05% |